Induction of connexin43 and gap junctional communication in PC12 cells overexpressing the carboxy terminal region of amyloid precursor protein

Journal of Neuroscience Research

Volumn 44, Issue 2, 1996, Pages 124-132

  Nagy, J I ^a,d   Hossain, M Z ^a   Hertzberg, E L ^b   Marotta, C A ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

A4 amyloid; Alzheimer's disease; connexin43; gap junctions; PC12 cells

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CONNEXIN 43; LUCIFER YELLOW;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL JUNCTION; CELL MEMBRANE; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENE INDUCTION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; CELL COMMUNICATION; CONNEXIN 43; FLUORESCENT ANTIBODY TECHNIQUE; GAP JUNCTIONS; GENE EXPRESSION; HUMANS; MICROSCOPY, ELECTRON; PC12 CELLS; PEPTIDE FRAGMENTS; RATS; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0029917161     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960415)44:2<124::AID-JNR4>3.0.CO;2-F     Document Type: Article

References (42)

1. Anderson JP, Esch FS, Keim PS, Sambamurit K, Lieberburg I, Robakis NK (1991): Exact cleavage site of Alzheimer amyloid precursor in neuronal PC12 cells. Neurosci Lett 128:126-128.
2. Beyer EC (1993): Gap junctions. Int Rev Cytol 137:1-37.
3. Beyer EC, Paul DL, Goodenough DA (1987): Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J Cell Biol 105:2621-2629.
4. Eghbali B, Kessler JA, Dougherty M, Hsu H, Chanson M, Spray DC (1991): Expression of connexin26 gap junction channels in cells with neuronal phenotype. Soc Neurosci Abstr 17:1334.
5. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, Mclure D, Ward PJ (1990): Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248:1122-1124.
6. Estus S, Golde T, Kunishita T, Blades D, Lowery D, Eisen M, Usiak M, Qu X, Tabira T, Greenberg B, Younkin S (1992): Potentially amyloidogenic, carboxy-terminal derivatives of the amyloid protein precursor. Science 255:726-728.
7. Fukuchi KI, Kamino K, Deeb SS, Furlong CE, Sundstrom JA, Smith AC, Martin CM (1992a): Expression of a carboxy-terminal region of the β-amyloid precursor protein in a heterogeneous culture of neuroblastoma cells: evidence for altered processing and selective neurotoxicity. Mol Brain Res 16:37-46.
8. Fukuchi KI, Kamino K, Deeb SS, Smith AC, Dang T, Martin GM (1992b): Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity. Biochem Biophys Res Commun 182:165-173.
9. Gandy SE, Bhasin R, Ramabhadran TV, Koo EH, Price DL, Goldgaber D, Greengard P (1992): Alzheimer β/A4 amyloid precursor protein, evidence for putative amyloidogenic fragment. J Neurochem 58:383-386.
10. Gardella JE, Gorgone GA, Candela L, Ghiso J, Castano EM, Frangione B, Gorevic PD (1993): High-level expression and in vitro mutagenesis of a fibrillogenic 109-amino acid C-terminal fragment of Alzbeimer's disease amyloid precursor protein. Biochem J 294:667-674.
11. Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG (1992): Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255:728-730.
12. Haass C, Schlossmacher MG, Jung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Kook EH, Schenk D, Teplow DB, Selkoe DJ (1992): Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359:322-325.
13. Hertzberg EL, Disher RM, Tiller AA, Zhou Y, Cook RG (1988): Topology of the Mr 27,000 liver gap junction protein. Cytoplasmic localization of amino- and carboxyl termini and a hydrophobic domain which is protease-hypersensitive. J Biol Chem 263:19105-19111.
14. Hossain MZ, Murphy LJ, Hertzberg EL, Nagy JI (1994): Phosphorylated forms of connexin43 predominate in rat brain: demonstration by rapid inactivation of brain metabolism. J Neurochem 62:2394-2403.
15. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988): Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331:531-534.
16. Lustig RH, Hua P, Wyu W, Ahmad FJ, Baas PW (1994): An in vitro model for the effects of estrogen on neurons employing estrogen receptor-transfected PC12 cells. J Neurosci 14:3945-3957.
17. Maestre GE, Tate B, Majocha RE, Marotta CA (1992): Cell surface extensions associated with overexpression of Alzheimer β/A4 amyloid. Brain Res 599:64-72.
18. Maestre GE, Tate BA, Majocha RE, Marotta CA (1993): Membrane surface ruffling in cells that overexpress Alzheimer amyloid β/A4 C-terminal peptide. Brain Res 621:145-149.
19. Maestre GE, Tate BA, Majocha RE, Maguire J, Marotta CA (1994): Intercellular interactions in cells overexpressing β/A4-C-terminal DNA. Scanning Microsc 8:325-336.
20. Majocha RE, Reno JM, Van Haight C, Lyle LR, Freidland RP, Marotta CA (1992a): Development of a monoclonal antibody specific for β/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid angiopathy. J Nucl Med 33:2184-2189.
21. Majocha RE, Tate B, Marotta CA (1992b): PC12 cells release stimulatory factors after transfection with β/A4 C-terminal DNA of the Alzheimer amyloid precursor protein. Cell Mol Neurobiol 18:99-113.
22. Marotta CA, Chou WG, Majocha RE, Watkins R, Zain SB (1989): Overexpression of amyloid precursor protein A4 (β-amyloid) immunoreactivity in genetically transformed cells. Implications for a cellular model of Alzheimer amyloidosis. Proc Natl Acad Sci USA 86:337-341.
23. Maruyama K, Terakado K, Usami M, Woshikawa K (1990): Formation of amyloid like fibrils in cos cells overexpressing part of the Alzheimer amyloid protein precursor. Nature 347:566-569.
24. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther I (1985): Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249.
25. Musil LS, Goodenough DA (1991): Biochemical analysis of connexin43 intracellular transport, phosphorylation. and assembly into gap junctional plaques. J Cell Biol 115:1357-1374.
26. Nagy JI, Dermietzel R (1996). Gap junctions and connexins in the mammalian central nervous system. In Hertzberg EL (ed): "Advances in Molecular and Cell Biology," vol. 18. New York: JAI Press (in press).
27. Nagy JI, Hacking J, Frankenstein UN, Turley EA (1995a): Requirement of the hyaluronan receptor RHAMM in neurite extension and motility as demonstrated in primary neurons and neuronal cell lines. J Neurosci 64:61-70.
28. Nagy JI, Hossain MZ, Lynn BD, Curpen GE, Turley EA (1995b): Increased connexin43 and gap junctional communication correlates with altered phenotypic characteristics of cells overexpressing the hyaluronan receptor RHAMM. Cell Growth Differ (in press).
29. Paul DL (1986): Molecular cloning of cDNA for rat liver gap junction protein. J Cell Biol 103:123-134
30. Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B (1988): A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors. Nature 331:525-527.
31. Ripellino JA, Vassilacopoulou D, Robakis NK (1994): Solubilization of full-length amyloid precursor proteins from PC12 cell membranes. J Neurosci Res 39:211-218.
32. Saez JC, Berthoud VM, Moreno AP, Spray DC (1993): Multiplicity of controls in differentiated and undifferentiated cells and possible functional implications. In Shenolikar S, Nairn AC (eds): "Advances in Second Messenger and Phosphoprotein Research," vol. 27. New York: Raven Press, pp 163-198.
33. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990): Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248:492-495.
34. Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve RL (1988): Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331:528-530.
35. Tate B, Aboody-Guterman KS, Morris AM, Walcott EC, Majocha RE, Marotta CA (1992): Disruption of circadian regulation by brain grafts that overexpress Alzheimer β/A4 amyloid. Proc Natl Acad Sci USA 89:7090-7094.
36. Traub O, Look J, Dermietzel R, Brummer F, Hulser D, Willecke K (1989): Comparative characterization of the 21-kD and 26-kD gap junction proteins in murine liver and cultured hepatocytes. J Cell Biol 108:1039-1051.
37. Turley EA, Hossain MZ, Serokan T, Jordan LM, Nagy JI (1994): Astrocyte and microglial motility in culture is functionally dependent on the hyaluronic acid receptor RHAMM. Glia 12:68-80.
38. Vasilliev JM (1985): Spreading of non-transformed and transformed cells. Biochem Biophys Acta 780:21-65.
39. Wolf D, Quyon D, Wang Y, Cordell B (1990): Identification and characterization of C-terminal fragments of the β-amyloid precursor produced in cell culture. EMBO J 9:2079-2084.
40. Yamamoto T, Ochalski A, Hertzberg EL, Nagy JI (1990): On the organization of astrocytic gap junctions in rat brain as suggested by LM and EM immunohistochemistry of connexin43 expression. J Comp Neurol 302.853-883.
41. Yankner BA, Danes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL (1989): Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245:417-420.
42. Zain SB, Salim M, Chou W-G, Sajdel-Sulkowska EM, Majocha RE, Marotta CA (1988): Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer brain. Coding and noncoding regions of the fetal precursor mRNA are expressed in the Alzheimer cortex. Proc Natl Acad Sci USA 85:929-933.